Ping Cheng

Arctic Vision is a China-based ophthalmic biotech focusing on breakthrough therapies, with a leading portfolio covering pre-clinical stage to commercial stage products. Based in China with global ambitions, we are committed to harnessing deep end-user insights and unlocking ophthalmic innovations to bring eye products and therapies that solves unmet clinical needs and benefit patients and consumers. Arctic Vision is led by an elite team of ophthalmic industry veterans with proven domestic and global track record in the successful research and development, and commercialization of eye care products. We are backed by recognized life science investors and biotechnology venture capital with broad networks in China, Asia, United States and Europe ophthalmic markets, in-depth industry knowledge and longstanding experience in business incubation. We work as trusted partners to global biopharmaceutical companies looking to access the Chinese market and drive long-term strategic clinical development and growth. Arctic Vision is driven by our dual-engine growth strategy, cutting-edge technology and consumer-oriented technology, which marrying advances in bioscience and technology, with real-time market needs and demand, to bring ophthalmology innovations that are truly meaningful and game changing. Across the business, we constantly push the boundaries of exploration and innovation to get higher and further in the quest to improving vision for mankind. Our goal is for people to see clearer, live better. At Arctic Vision, that is our promise, and our motivation.